The following antibodies were used for western blotting, immunoprecipitations, and immunofluorescence:
total β-catenin (1:2,000) (Cell Signaling #9562),
phospho-β-catenin S33/S37/T41 (1:1,000) (Cell Signaling #9561),
phospho-β-catenin S45 (1:1,000) (Cell Signaling #9564),
α-tubulin (1:2,000) (Cell Signaling #2144), PARP (1:1,000) (Cell Signaling #9542), pY99 (1:500) (Santa Cruz sc-7020), HA (1:1,000) (Cell Signaling #3724), Myc (1:1,000) (Cell Signaling #2276),
Flag (1:100,000) (Sigma #F3165), GST (1:1,000) (Cytiva 27-4577-01),
E-cadherin (1:1,000) (BD #610181),
E-cadherin (Proteintech #20874-1-AP), phospho-Lrp6 S1490 (1:1,000) (Cell Signaling #2568), phospho-Tau S202/T205 (1:1,000)(Cell Signaling #30505). Secondary antibodies used for western blotting were
anti-rabbit-HRP (1:5,000 or 1:10,000) (Jackson ImmunoResearch #115-035-003),
anti-mouse-HRP (1:5,000 or 1:10,000) (Jackson ImmunoResearch #111-035-003),
IRDye 800CW goat anti-mouse (1:16,666) (LI-COR Biosciences #926-32210),
IRDye 680RD goat anti-mouse (1:33,333) (LI-COR Biosciences #926-68070). Where applicable, western blotting dilutions are denoted in parentheses.
Dutt P., Haider N., Mouaaz S., Podmore L, & Stambolic V. (2024). β-catenin turnover is regulated by Nek10-mediated tyrosine phosphorylation in A549 lung adenocarcinoma cells. Proceedings of the National Academy of Sciences of the United States of America, 121(19), e2300606121.